W
Walter J. Curran
Researcher at Emory University
Publications - 751
Citations - 45336
Walter J. Curran is an academic researcher from Emory University. The author has contributed to research in topics: Radiation therapy & Lung cancer. The author has an hindex of 86, co-authored 742 publications receiving 38522 citations. Previous affiliations of Walter J. Curran include Fox Chase Cancer Center & Washington University in St. Louis.
Papers
More filters
Journal ArticleDOI
Clinical stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (N1 disease).
Seth A. Rosenthal,Seth A. Rosenthal,Walter J. Curran,Scoff H. Herbert,Edward N. Hughes,Howard M. Sander,Patrick M. Stafford,W. Gillies McKenna +7 more
TL;DR: The prognosis of patients with clinically staged hilar nodal involvement (Stage N1) or clinical Stage II non‐small cell lung cancer (NSCLC, Stage T1‐2N1M0) treated with radiation therapy (RT) alone is not well established.
Journal ArticleDOI
Prospective Evaluation of Quality of Life and Neurocognitive Effects in Patients With Multiple Brain Metastases Receiving Whole-Brain Radiotherapy With or Without Thalidomide on Radiation Therapy Oncology Group (RTOG) Trial 0118
Benjamin W. Corn,Jennifer Moughan,Jonathan P.S. Knisely,Sherry W. Fox,Arnab Chakravarti,W. K. Alfred Yung,Walter J. Curran,H. Ian Robins,David Brachman,Randal H. Henderson,Minesh P. Mehta,Benjamin Movsas +11 more
TL;DR: Quality of life and neuropsychological testing can be prospectively administered on a Phase III cooperative group trial and Baseline SQLI is predictive of survival, despite neurocognitive declines, QOL remained stable during treatment and follow-up.
Journal ArticleDOI
Machine learning in quantitative PET: A review of attenuation correction and low-count image reconstruction methods.
TL;DR: The developments of machine learning methodology are presented, ranging from random forest and dictionary learning to the latest convolutional neural network-based architectures for PET attenuation correction and low-count image reconstruction in quantitative positron emission tomography.
Journal ArticleDOI
Patterns of failure in patients with stage I, grade 3 carcinoma of the endometrium.
Kathryn M. Greven,Mark Randall,James Fanning,Marianne Bahktar,Paul H. Duray,Albert J. Peters,Walter J. Curran +6 more
TL;DR: Clinical investigation into the value of systemic therapy is necessary in patients with FIGO Stage I, grade 3 endometrial carcinomas because patients with high grade tumors do have a propensity for distant metastasis.
Journal ArticleDOI
Phase I Study of Topotecan Plus Cranial Radiation for Glioblastoma Multiforme: Results of Radiation Therapy Oncology Group Trial 9507
TL;DR: Toxicity was acceptable at an IV topotecan dose of 1.5 mg/m(2)/d administered daily for 5 days every 21 days for three cycles of cranial radiotherapy for glioblastoma multiforme.